Versus other EGFR inhibitors, osimertinib showed longer progression free survival time
Finding the best treatment for cancer. Complementary and alternative cancer therapies that are scientifically proven.
Versus other EGFR inhibitors, osimertinib showed longer progression free survival time
Leave a comment